Axcella Health Inc   (AXLA)
Other Ticker:  
Price: $0.4009 $-0.04 -8.886%
Day's High: $0.5095 Week Perf: -19.82 %
Day's Low: $ 0.36 30 Day Perf: -91.25 %
Volume (M): 7 52 Wk High: $ 41.25
Volume (M$): $ 3 52 Wk Avg: $6.65
Open: $0.36 52 Wk Low: $0.34

 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 3
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -48
 Cash Flow (TTM) (Millions $) -25
 Capital Exp. (TTM) (Millions $) 0

Axcella Health Inc
Axcella Health Inc is a biotechnology company that is focused on discovering and developing novel, multi-targeted interventions to improve the lives of patients with complex diseases and conditions. The company uses its proprietary platform, called EMMET, to build a deep understanding of biology and develop clinical candidates.

Axcella is primarily focused on the development of endogenous metabolic modulators (EMMs), which are naturally occurring molecules that help regulate metabolism. These EMMs have the potential to address multiple underlying pathways associated with various diseases and conditions.

The company's pipeline includes candidates for liver, muscle, and blood disorders, as well as oncology. Axcella is dedicated to advancing these candidates through clinical studies to generate data and obtain regulatory approvals.

Axcella Health Inc combines its innovative science with a patient-centric approach, aiming to bring safe and effective treatments to those in need. The company's mission is to transform the lives of patients through the development of novel therapies that leverage the power of the body's own systems.

   Company Address: P.O. Box 1270 Littleton 1460 MA
   Company Phone Number: 320-2200   Stock Exchange / Ticker: NASDAQ AXLA


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Axcella Health Inc

Unanticipated Operating Loss Hits Axcella Health Inc. in Q2 2023; Stuns Stockholders Despite Steady Top-Line

Axcella Health Inc, a renowned corporation in the healthcare sector, recently released its financial results for the second quarter of 2023. Notable improvements were observed in the company's operating loss, reflecting a more efficient approach to business operations. This article explores the impact of these financial results on Axcella Health Inc and analyzes how they may shape the company's future trajectory.
1. Stability in Top-Line Performance:
The stockholders have not anticipated any changes in the company's top-line over the earnings season from April to June 2023. While it may seem uneventful, this stability is crucial for the company's growth prospects. By maintaining a consistent top-line, Axcella Health Inc can better forecast and allocate resources, allowing for more effective long-term planning.

Axcella Health Inc

Axcella Health Inc Reports Operating Deficit in Q1 2023, Raises Concerns for Investors2.

Investing in the stock market can be quite a challenging task, especially when there is uncertainty around the company's financial performance. Axcella Health Inc has recently recorded a cumulative net loss of $-66 million in the 12 months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -235.19%. This news can be quite concerning for investors, as negative ROA points towards the fact that the company is not generating enough profits with the assets it owns.
Moreover, within the Healthcare sector, 223 other companies have a higher return on assets, indicating that there are better opportunities in the market. However, the positive news is that the overall ranking for ROA has advanced in the Mar 31, 2023, quarter, which means that the company is moving towards profitability, but still not there yet.



About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com